

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float


Silence Therapeutics Appoints Mark Rothera As CEO; Annual Loss Widens


(Sharecast News) - Drug discovery and development company Silence Therapeutics announced the appointment of Mark Rothera as its president and chief ex...


IN BRIEF: Silence Therapeutics ADSs Begin Life On Nasdaq


UK Earnings, Trading Statements Calendar - Next 7 Days


Silence Therapeutics Files Registration Statement For ADS Listing


Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt


(Sharecast News) - RNA therapeutics developer Silence Therapeutics said on Tuesday that it had continued to make "exceptional progress" in securing ad...